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I realized when I came here that this is predominantly an audience 
of non-physicians, so I thought maybe it might be more appropriate to 
talk about how medicine has impacted in non-medical areas. This may 
be especially important here because this is a liberal arts school. Some, 
and possibly much of what I say will be of direct interest to people who 
are not working in the field of medicine or even in science. There is a 
tremendous interface of interest between science and the humanities. 
What happens in medicine greatly influences practices in the humanistic 
specialties. 
The role of modern medicine in society has been amplified by its 
almost unbelievable successes. The talks of this morning have emphasiz-
ed how foreshortened is the history of science. Joe Holmes, whose name 
was mentioned as the father of ultra-sonography, worked at the U niver-
sity of Colorado. He also was one of the first people in the United States 
who realized the practical application of artificial kidneys. It was my good 
fortune 20 years ago to go to a university where a man like this was at 
work. You will be interested to know that Dr. Holmes is still extremely 
active. He would take immense pleasure in knowing, as Dr. Miller has 
told us, that there is a possibility that ultrasound techniques eventually 
may be found to be more discriminating and more valuable than the 
classical CAT scan (Computerized Axial Tomography). 
The beginnings of other developments are also recent, and occur-
red under my eyes. I had the great pleasure a number of years ago, to 
go to the University of Minnesota to review the exciting developments 
there in cardiac surgery. I can only contrast what I saw there with the 
very modest statement made today by Dr. Warden that he played a minor 
role in the development of that program. Dr. Warden was the main per-
son from whom Drs. Henry Bahnson, Merrill Brown, myself, and others 
from Johns Hopkins went to learn. Herb, I am sure that you remember 
our visit in 1953. 
What I would like to do now is to tell you about developments in 
another field, transplantation, and to focus on how these developments 
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have influenced how we think in law, religion, philosophy and many other 
areas not excluding government. These events also have occurred in a 
relatively short time. Prior to 1960, it was thought that transplantation 
of any organ, including the kidney, but also including the heart and liver, 
was a biological impossibility. This pessimism was based on research in 
small animal models in which it was observed that rejection, once started 
and despite efforts at therapy, moved on to the distruction of the graft. 
The idea was ingrained that rejection was one of biology's most inex-
orable and strongest reactions. I remember reading an extremely 
pessimistic article in the New England Journal of Medicine in 1959 by 
Burnett, the Nobel laureate from Australia, assessing the prospects of 
successful transplantation as a fundamental impossibility, 
Within 36 months of the appearance of that article, it became pos-
sible in our first series of kidney transplants, to reverse rejection, using 
relatively simple methods, and then later to observe in these patients a 
long term survival. Some of those first patients are stilI alive almost 20 
years later. It was possible to later reduce the amount of immunosup-
pressive medication that the patients needed and so, in increasing 
numbers, the recipients returneq to society. They came from the hospital 
wards, to be productive people who could go to restaurants, have babies, 
finish college, and even to go back into the practice of medicine, nursing 
or other areas in which they had systematic exposure to infectious diseases 
as they cared for other sick people. We realized at the outset that there 
were marvelous possibilities for a revolution in medicine. 
The techniques that were developed with renal transplantations were 
applied directly with the transplantations of all organs. It is inconceivable 
that development of new immuno-repressive programs could really be 
done with the heart, liver, and lungs. Even today, the kidney transplants 
continue to be the model for which progress is based for transplantation 
of all other organs. 
By 1963, successes in renal transplantation were being generated 
in Denver, Boston (at the Peter Bent Brigham Hospital) and the Medical 
College of Virginia where the late Dave Hume worked. There was little 
public understanding of what actually had been achieved. Early in 1964, 
there appeared an editorial in the "Annals of Internal Medicine" written 
by the editor of that august journal, Dr. J. Russell Elkinton, condemn-
ing these attempts at what he considered human experimentation. 
I don't even remember the title of the article except that in it was 
contained the flash word "cannibalization," as well as references to possi-
ble violations of ethical codes. Dr. Eklinton was an extremely fine man 
who, I believe, almost immediately realized the potential harm that the 
editorial could do. He solicited responses from various people, including 
myself. These were published but by this time, the editorial was already 
out of date. It had become clear that a new chapter was at hand in 
medicine and in the treatment of end-stage renal disease. The ethical ques-
tions of transplantation were not thereby brushed away. 
Seminars and meetings came as a result, of which I believe the most 
important was at the Ciba Foundation in London in 1965. It was a very 
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small meeting. There were only 25 members. Most were non-physicians. 
The U.S. medical contingent included Dr. Joseph Murray from Boston, 
George Schreiner of Washington, D.C. and myself. There were represen-
tatives from law, such as Lord High Justice Kilbrandon, who was the 
British counterpart of our Supreme Court Chief Justice. Other really in-
teresting participants included David Daube, Regis Professor of Law at 
Oxford, who had spent and survived 4 years in a German concentration 
camp; the nephrologist, Professor Herbert de Wordener who had lived 
out a similar period of incarceration, and the surgeon Sir Michael 
Woodruff who had commanded a battalion of men imprisoned by the 
Japanese during the second World War. These last 3 men had a deep 
and abiding interest in the protection of human rights, which in their 
specific cases had been so totally violated. 
The mere fact that transplantation had become a technological suc-
cess didn't mitigate the somber tone of the meeting. Amongst other things 
considered was the appropriateness of donation of organs. In the early 
and mid 1960's, because of the legal and social situation at that time, 
the most convenient and usually the only donors for patients, were from 
within the family. The legal basis was examined of a process in which 
a completely healthy, but well motivated person, was physically assaulted 
by the removal of an organ which was used to save the life of another 
person. On the surface, it was a perfectly satisfactory chain of events in 
the context of Judeo-Christian theology being comparable, I suppose, 
to leaping into a lake to pull someone out who is drowning. But there 
were many concerns about the conditions under which these donations 
were taking place. 
The legal basis for donation went back inevitably to a 1954 
Massachusetts court ruling which had permitted an identical twin 
transplantation. With identical twins, there is no biological barrier and 
no rejection. It is a matter of transferring tissue from one person to 
another, doing a technically adequate job, and then having the organ 
function. The opinion of the judge reflected the probability that iden-
tical twins were so close, emotionally as well as in every other way, that 
the loss of a kidney by the donor would be less devastating in the holistic 
sense, than would be the loss of his identical twin. The same reasoning 
in subsequent court cases has been upheld and extended to other renal 
donations by parents to their offspring and so on down the list. It would 
take a great stretch of the imagination to extend this concept to transplan-
tation from other living donors, as for example, using donors who were 
convicts. 
I have been in the field long enough to have seen many examples 
of donor abuse, especially within families. The result could be the family 
power structure focusing on a donor within their midst on the basis of 
his or her presumed expendability in the eyes of the rest of the family. 
A mentally retarded person would often be singled out. I saw examples 
in which refusal of donation brought ostracism within the family, or alter-
natively a reluctant sacrifice being offered to someone for whom there 
was very little affection. 
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In connection with possible coercion, another issue went right straight 
back to the original Boston case of identical twins. The question was 
whether anyone could be a true volunteer if they don't have full posses-
sion of their civil rights. The original Boston twin donor was a minor, 
and subsequently, identical twins donors as young as 11 years of age have 
been used. Such donors must answer to their parents and thus are cap-
tive. The same captive concept applies to convicts, who could be induced 
by emoluments or other favors to step forward to give a kidney even 
though they have lost their full civil rights. To me, the concept of living 
donation remains a troubling one. Although I was one of the first to use 
that expediency, I have not, for a number of years, been willing to operate 
on well people in order to treat sick people. 
Obtaining organs from dead people is the alternative solution. At 
the Ciba meeting in 1965, there surfaced for the first time from Euro-
pean centers, the concept of brain death, in which organs were removed 
from "heart-beating" cadavers. At first, the idea was apalling, at least 
to me, because I could envision an accident victim whose therapy would 
be jeopardized by virtue of his or her candidacy to be a donor. 
The practice of cadaveric donation under these circumstances had 
been already in place in Belgium for some time. Subsequently I realized 
that with the collaboration of the neurosurgeons, neurologists and other 
specialists the chances of a brain-dead donor being properly cared for 
were actually greatly increased by virtue of the redefinition of death in 
accordance with brain function rather than by the old conventional criteria 
of cessation of heartbeat and respiration. Under the previous cir-
cumstances, when somebody with a serious brain injury was brought to 
an emergency room, it was often obligatory to try to make a decision 
on the spot whether the patient could survive. A negative decision pre-
cluded resuscitation. Under the new definitions of brain-death and their 
wide acceptance in the western world, all such patients have a fair trial 
at resuscitation. Then, in an orderly way, it can be determined whether 
they are merely heart/lung preparations or if they have some prospect 
of having brain function restored. The quality of care and the discriminate 
application of such care to terribly damaged people with central nervous 
system injury, was improved by the highly responsible actions of 
neurologists and neurosurgeons throughout the world. 
In the meanwhile, to make all this legal, there was a subtle but 
definite change in the laws whereby state by state, and now involving 
all states, "brain death" is the definition of death, and not the cessation 
of respiration and heartbeat. If as I stood here, I had a heart attack and 
fell to the ground, there wouldn't be a doctor in the audience who would 
consider me dead even if my heart had stopped. Efforts would be made 
to resuscitate me. If this accident occurred while I was having a tonsilec-
tomy, and my surgeon was incapable or untrained in resuscitation, he 
could be sued for not knowing what to do. Irreversible brain damage 
is now the definition of death and properly so. 
People interested in these issues should examine and read carefully 
the basic documents upon which we must base our practices. These are 
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the Nuremberg Code, which is only six or seven pages long, and its 
predecessor the Helsinki Declaration which is only one page in length 
and simply stated. These documents divide what is human experimen-
tation into two categories: One, the type of advanced therapy that can 
be, if it is successful, of direct and immediate benefit to the person who 
submits himself for care, and Two, the kind of human investigation which 
might benefit mankind, but which will not directly benefit the person 
upon whom experimentation is done. Those are important documents 
in everyone's surgical conscience which can easily be lost sight of if there 
is excessive zeal to obtain scientific information about human beings. 
As we look at the Nuremberg Code and the Helsinki Declaration, 
it is important to realize that in caring for critically ill patients, pure ex-
periments can sometimes not be done. At a recent American Surgical 
Association meeting, a paper was presented by a South African Surgeon 
describing a "controlled randomized trial" assessing how bleeding from 
vessels in the lower esophagus can be effectively controlled by a series 
of techniques. Bleeding could be stopped by a simple injection technique 
at the rate of95%. In the discussion a group from one of the major U.S. 
universities talked about a similar randomized control study in which 
as a first step, they placed an instrument down the esophagus where they 
could see the bleeding coming across in spurts to the opposite wall. In 
spite of the fact that they knew that they could control the hemorrhaging 
immediately in 95 % of the cases, they then went to a drawer, pulled a 
card, or in essence flipped a coin, to see whether they should do that now 
proven form of therapy, or take the instrument of salvation out and em-
bark on a less effective plan of treatment. 
I cannot simply understand that kind of a trial and yet, in all major 
universities, I am sad to say, even including the one where I now work, 
this practice is amost a reflex. We have to examine those practices because 
I do think they constitute a potential violation of those very documents 
upon which we base our medical practice. 
Earlier today, we heard from Dr. Warden of the high cost of ex-
ploiting bona fide advances in medicine, with panicular reference to cor-
onary anery surgery. The same applies in the treatment of end stage renal 
disease in which there is, perhaps the best example, ever, of excessive 
costs. In 1973 there was passed a rider on the Social Security law which 
may have been the most noble act of medical legislation yet put into place. 
It socialized a disease since it paid for the care of all people with end-
stage renal disease providing they had a Social Security number. Until 
then, the problems of keeping someone alive with end-stage renal disease 
were staggering. One couldn't obtain dialysis because it was too expen-
sive. Transplantation was the only alternative but it was not widely 
available. Families bankrupted themselves in desperate efforts to keep 
one of their members alive. 
With the passage of the 1973 law, it became not only feasible to put 
patients on end-stage renal disease programs, but in many pans of the 
country there developed competition for that Federal money which has 
grown to a total this year of $2 billion. The bill in 1984 is projected to 
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be $4 billion. I have sometimes been ashamed to see physicians or 
surgeons who are paid from this reservoir driving their custom made 
Mercedes Benz. That is not really why we are supposed to be here. 
There is another bad side of the syndrome of excessive money which 
contributes to the fixation of therapeutic practices at an unsatisfactory 
level. I have seen violent resistance to change by members of end stage 
renal disease groups because change is going to affect the way the business 
is transacted. People who are not in medicine can do something about this. 
I promised at the beginning not to talk about medicine, and yet what 
I have said has everything to do with medicine, its practice. and its respon-
sibilities. In my field, as we look ahead and view the prospects of 
transplanting all major organs successfully, the ethical and other issues 
I touched on will become all the more pressing. There have been major 
recent developments in transplantation which will move this form of 
therapy from its present unreliable state onto a new plane. There is a 
new drug available now which is so powerful that it permits the chronic 
survival of kidney grafts at a near perfect rate. It is being applied to the 
transplantation of other organs. The drug is a fungus extract called 
cyclosporin A. It is being tested at the University of Pittsburgh. 
One of the tragedies of life always has been that young people must 
die or suffer because of the malfunction or failure of a single organ but 
with all other organs viable and functioning. It is an electrifying thought 
to realize how effectively these patients will be treated in the years ahead. 
I think that the 1980's will be the time when transplantation, which didn't 
fully flower in spite of its marvelous promise in the early 1960's, will come 
to maturity. It will then have to come to terms with its own destiny in 
all of the other ways than its own successful technology. 
